Activating Point Mutations in the MET Kinase Domain Represent a Unique Molecular Subset of Lung Cancer and Other Malignancies Targetable with MET Inhibitors
MET激酶结构域中的激活点突变代表了肺癌和其他恶性肿瘤的一个独特的分子亚群，这些亚群可作为MET抑制剂的靶点。
期刊:Cancer Discovery
影响因子:29.7
doi:10.1158/2159-8290.CD-23-1217
Federica Pecci #,Seshiru Nakazawa #,Biagio Ricciuti,Guilherme Harada,Jessica K Lee,Joao V Alessi,Adriana Barrichello,Victor R Vaz,Giuseppe Lamberti,Alessandro Di Federico,Malini M Gandhi,Dimitris Gazgalis,William W Feng,Jie Jiang,Simon Baldacci,Marie-Anaïs Locquet,Felix H Gottlieb,Monica F Chen,Elinton Lee,Danielle Haradon,Anna Smokovich,Emma Voligny,Tom Nguyen,Vikas K Goel,Zachary Zimmerman,Sumandeep Atwal,Xinan Wang,Magda Bahcall,Rebecca S Heist,Sumaiya Iqbal,Nishant Gandhi,Andrew Elliott,Ari M Vanderwalde,Patrick C Ma,Balazs Halmos,Stephen V Liu,Jianwei Che,Alexa B Schrock,Alexander Drilon,Pasi A Jänne #,Mark M Awad #
